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Abstract
Objective:  To  evaluate  the  Western  blotting  method  for  the  detection  of  IgG  anti-Toxoplasma
gondii (T.  gondii)  (IgG-WB)  in  the  serum  of  children  with  suspected  congenital  toxoplasmosis.
Methods: We  accompanied  47  mothers  with  acquired  toxoplasmosis  in  pregnancy  and  their
children, between  June  of  2011  and  June  of  2014.  The  IgG-WB  was  done  in  house  and  the  test
was considered  positive  if  the  child  had  antibodies  that  recognized  at  least  one  band  on  IgG
blots different  from  the  mother’s  or  with  greater  intensity  than  the  corresponding  maternal
band, during  the  ﬁrst  three  months  of  life.
Results:  15  children  (15.1%)  met  the  criteria  for  congenital  toxoplasmosis  and  32  (32.3%)  had  the
diagnosis excluded.  The  symptoms  were  observed  in  12  (80.0%)  children  and  the  most  frequent
were cerebral  calciﬁcation  in  9  (60.0%),  chorioretinitis  in  8  (53.3%),  and  hydrocephalus  in  4
(26.6%). IgM  antibodies  anti-T.  gondii  detected  by  chemiluminescence  (CL)  were  found  in  6
(40.0%) children  and  the  polymerase  chain  reaction  (PCR)  for  detection  of  T.  gondii  DNA  was
 Please cite this article as: Capobiango JD, Monica TC, Ferreira FP, Mitsuka-Breganó R, Navarro IT, Garcia JL, et al. Evaluation of the
estern blotting method for the diagnosis of congenital toxoplasmosis. J Pediatr (Rio J). 2016;92:616--23.
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positive  in  5  of  7  performed  (71.4%).  The  sensitivity  of  IgG-WB  was  of  60.0%  [95%  conﬁdence
interval (CI)  32.3--83.7%]  and  speciﬁcity  43.7%  (95%  CI  26.7--62.3%).  The  sensitivity  of  IgG-WB
increased to  76.0  and  89.1%  when  associated  to  the  research  of  IgM  anti-T.  gondii  or  PCR,
respectively.
Conclusions:  The  IgG-WB  showed  greater  sensitivity  than  the  detection  of  IgM  anti-T.  gondii;
therefore,  it  can  be  used  for  the  diagnosis  of  congenital  toxoplasmosis  in  association  with  other
congenital  infection  markers.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Avaliac¸ão  do  método  Western  Blotting  para  diagnóstico  de  toxoplasmose  congênita
Resumo
Objetivo:  Avaliar  o  método  Western  Blotting  para  detecc¸ão  de  IgG  anti-Toxoplasma  gondii(T.
gondii) (IgG-WB)  no  soro  de  crianc¸as  com  suspeita  de  toxoplasmose  congênita
Métodos:  Acompanhamos  47  mães  com  toxoplasmose  adquirida  na  gravidez  e  seus  ﬁlhos,  entre-
junho de  2011  e  junho  de  2014.  O  IgG-WB  foi  feito  internamente  e  o  teste  foi  consideradopositivo
quando a  crianc¸a  apresentava  anticorpos  que  reconheciam  pelo  menos  uma  bandanas  man-
chas de  IgG  diferente  das  bandas  da  mãe  ou  com  maior  intensidade  do  que  a  bandamaterna
correspondente,  durante  os  primeiros  3  meses  de  vida
Resultados:  Atenderam  aos  critérios  para  diagnóstico  de  toxoplasmose  congênita  15crianc¸as
(15,1%) e  32  (32,3%)  tiveram  o  diagnóstico  excluído.  Os  sintomas  foram  observados  em12
crianc¸as (80%)  e  os  mais  frequentes  foram  calciﬁcac¸ão  cerebral  em  nove  (60%),  coriorre-
tiniteem oito  (53,3%)  e  hidrocefalia  em  quatro  (26,6%).  Os  anticorpos  IgM  anti-T.  gondii
detectadospor  quimiluminescência  (QL)  foram  encontrados  em  seis  crianc¸as  (40%)  e  a  reac¸ão
em cadeiada  polimerase  (RCP)  para  detecc¸ão  do  DNA  de  T.  gondii  foi  positiva  em  cinco  de
sete reac¸ões(71,4%).  A  sensibilidade  do  IgG-WB  foi  de  60%  [intervalo  de  conﬁanc¸a  (IC)  de  95%,
32,3 a  83,7%]e  a  especiﬁcidade  foi  de  43,7%  (IC  de  95%,  26,7  a  62,3%).  A  sensibilidade  do  IgG-
WB aumentoupara  76  e  89,1%  quando  relacionada  à  pesquisa  de  IgM  anti-T.  gondii  ou  à  RCP,
respectivamente
Conclusões:  O  IgG-WB  mostrou  maior  sensibilidade  do  que  a  detecc¸ão  de  IgM  anti-T.
gondii;portanto,  pode  ser  usado  para  o  diagnóstico  de  toxoplasmose  congênita  em  associac¸ão
comoutros  marcadores  de  infecc¸ão  congênita.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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Most  children  with  congenital  toxoplasmosis  (CT)  show  no
signs  or  symptoms  at  birth,  yet  there  is  a  risk  of  devel-
oping  late  sequelae,  particularly  ocular  and  neurological
impairment.1
All  children  are  considered  suspect  whose  mothers  had
acute  toxoplasmosis  in  the  course  of  pregnancy;  therefore,
these  children  must  be  subjected  to  serological  investiga-
tion  with  antibody  detection  for  anti-Toxoplasma  gondii  (T.
gondii).1,2
However,  a  conﬁrmed  serological  diagnosis  of  T.  gondii
infection  through  the  detection  of  speciﬁc  IgM  and/or
IgA  antibodies  against  the  parasite  does  not  occur  in  all
1,3--5newborns. Therefore,  IgG  antibodies  against  T.  gondii  in
serial  serum  samples  must  be  analyzed  and  the  child  remains
under  outpatient  follow-up,  which  can  take  months  until  the
deﬁnitive  diagnosis.1,6
m
t
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tIn  an  infected  fetus,  IgG  and  IgM  antibodies  produced
gainst  the  antigenic  determinants  of  T.  gondii  may  differ
rom  those  anti-T. gondii  IgG  and  IgM  antibodies  detected
n  the  maternal  serum,  suggesting  a  neosynthesis  of  spe-
iﬁc  antibodies.  Thus,  children  with  CT  with  non-reactivity
n  conventional  tests  for  IgM  detection  have  been  diagnosed
n  the  ﬁrst  months  of  life  through  the  Western  blot  method
WB).7--9
There  is  a  need  for  early  and  rapid  diagnosis  using
 low  complexity  method  that  allows  the  reference  lab-
ratories  for  toxoplasmosis  to  differentiate  the  dubious
esults  obtained  using  the  routine  conventional  serologi-
al  methods,  such  as  indirect  immunoﬂuorescence  (IIF),
nzyme-linked  immunoassay  (ELISA),  and  immunoassay  of
icroparticles  using  chemiluminescence  (CL).  The  objec-
ive  of  this  study  was  to  evaluate  the  WB  method  for  the
etection  of  IgG  antibodies  against  T.  gondii  (IgG-WB)  in
he  serum  of  the  child  and  his/her  mother  with  acquired
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b18  
oxoplasmosis  in  pregnancy  to  assist  in  the  early  diagnosis
f  CT.
ethods
ubjects
he  population  was  comprised  of  women  with  suspected
cquired  toxoplasmosis  in  pregnancy  and  their  children,
ssisted  at  the  Pediatric  Infectious  Disease  Outpatient,
etween  June  of  2011  and  June  of  2014.  The  study  included
hildren  whose  mothers  demonstrated  reactivity  for  anti-
.  gondii  IgM  during  the  pre-natal  care.  The  blood  samples
f  child/mother  pairs  were  collected  simultaneously  during
he  ﬁrst  three  months  of  child’s  life  and  stored  at  −20 ◦C  for
B.  The  control  group  consisted  of  children  whose  moth-
rs  showed  suspected  acute  toxoplasmosis  during  pregnancy,
ut  did  not  meet  the  criteria  for  CT.2,10,11 In  this  period,  47
hildren  and  their  mothers  were  monitored.  Of  these,  15
15.1%)  children  were  diagnosed  with  CT  and  in  32  (32.3%),
his  diagnosis  was  excluded.  Pregnant  women  received  spi-
amycin  or  sulfadiazine  plus  pyrimethamine  and  folinic  acid
ntil  childbirth.  The  suspected  infected  children  received
ulfadiazine  plus  pyrimethamine  and  folinic  acid  until  the
eﬁnitive  diagnosis.
iagnostic  criteria  in  children
T  was  considered  when  the  child  presented  elevation  of
peciﬁc  anti-T. gondii  IgG  titers  in  sequential  samples  in  the
rst  months  of  his  life  and/or  the  persistence  of  T.  gondii
gG  titers  after  12  months  of  life  and/or  reactivity  for  anti-
.  gondii  IgM  and/or  chorioretinitis  and/or  lesion  of  central
ervous  system  (CNS)  with  reactivity  for  IgG  and/or  posi-
ivity  for  the  T.  gondii  DNA  using  polymerase  chain  reaction
PCR).2,10,11
erological  test  for  the  detection  of  anti-T.  gondii
gM and  IgG
he  serological  tests  performed  during  pre-natal  care
nd  on  samples  from  children  were  performed  by  con-
entional  routine  laboratory  methods.  Anti-T. gondii  IgG
ntibodies  were  determined  by  Indirect  immunoﬂuores-
ence  (IIF)12 (Immunoblot,  Biolab-Mérieux,  Rio  de  Janeiro,
J,  Brazil),  with  T.  gondii  obtained  from  ascitic  ﬂuid  of
nfected  mice,  and  chemiluminescence  (CL)  (Architect,  Sys-
em  Abbott--Wiesbaden,  Germany)  with  p30  (SAG1)  and  p35
GRA8)  recombinant  antigens  of  T.  gondii.  Anti-T. gondii  IgM
ntibodies  were  also  detected  using  CL  (Architect,  System
bbott--Wiesbaden,  Germany)  with  p30  antigen  and  total
ysate  of  T.  gondii.
.  gondii  antigens
ive  albino  female  mice,  aged  from  45  to  60  days  and  weigh-
ng  between  25  and  40  g  were  used  for  obtaining  RH  strain
achyzoites  of  T.  gondii.  The  animals  were  inoculated  by
ntraperitoneal  route  with  a  suspension  of  live  tachyzoites
105/mL)  in  sterile  saline  solution.  Forty-eight  hours  after
G
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he  inoculation,  the  exudate  was  obtained  by  washing  the
eritoneal  cavity  with  3.0  mL  of  sterile  saline  solution.  The
amples  were  passed  through  a  27G  needle  for  rupture  of
he  host  cells.  Later,  they  were  centrifuged  and  the  sedi-
ent  was  standardized  at  109 tachyzoites/mL  by  counting
n  a  Neubauer  chamber.13
he  IgG-WB  Method
he  proteins  of  T.  gondii  to  be  used  in  IgG-WB  were  quan-
iﬁed  using  the  Lowry  et  al.  method,14 and  polyacrylamide
el  12%  was  used  for  electrophoretic  separation  of  proteins
ith  subsequent  transfer  of  the  proteins  to  a  nitrocellulose
embrane  (iBlot® Gel  Transfer  System,  California,  USA).
he  nitrocellulose  paper  was  stained  with  Ponceau  and,
fter  washing  with  distilled  water,  the  nitrocellulose  strips
ere  cut  and  blocked  with  skim  milk  5%  plus  tris  buffered
aline  (TBS)  with  Tween®.  Washes  were  subsequently  per-
ormed  with  TBS  and  skim  milk  5%  and  then,  the  patient’s
erum  was  added  diluted  in  TBS  with  Tween  (Sigma--Aldrich,
O,  USA)  and  skim  milk  5%,  carried  out  washes,  and  added
onjugated  anti-human  IgG  (Invitrogen,  Life  Technologies  --
A,  USA)  diluted  in  TBS  with  Tween  (Sigma--Aldrich,  MO,
SA)  and  skim  milk  5%.  After  further  washes  the  authors
dded  the  chromogen  substrate  diaminobenzidine  (DAB)
.2%  (Acrös  Organics,  Thermo  Fisher  Scientiﬁc  --  Geel,  Bel-
ium)  and  hydrogen  peroxide  (100  L).  When  the  bands  were
isualized,  the  reaction  was  stopped  with  distilled  water.
ositive  and  negative  control  samples  for  anti-T. gondii  were
ncluded  in  each  test.
The  test  was  considered  positive  if  the  child  produced
ntibodies  that  recognized  at  least  one  band  of  protein  dif-
erent  from  the  mother  or  with  higher  intensity  than  the
orresponding  maternal  band  (Fig.  1),  characterizing  the
eosynthesis  of  anti-T. gondii  IgG  antibodies.15--18 To  control
he  subjectivity  of  reading,  two  independent  observers  read
he  IgG-WB  patterns  blindly  and  without  knowledge  of  the
revious  serological  results  of  the  conventional  tests;  there
as  concordance  in  100.0%  of  the  results.
The  speciﬁcity  of  the  IgG-WB  method  was  determined
ith  26  serum  samples  obtained  from  individuals  seroneg-
tive  for  toxoplasmosis  (anti-T.  gondii  IgG  and  IgM  non-
eactive  by  CL)  and  with  seroreactivity  to  antibodies  against
ther  pathogens,  such  as  Treponema  pallidum  (n  = 5),
rypanosoma  cruzi  (n  =  5),  Leishmania  spp.  (n  =  2),  Paracoc-
idioides  brasilienses  (n  =  5),  or  seroreactivity  to  serological
arkers  of  autoimmunity  disorders,  such  as  antinuclear  anti-
odies  (n  =  5)  and  anti-DNA  double  strand  antibodies  (n  =  4).
CR  for  detection  of  T.  gondii  DNA
he  DNA  was  extracted  from  peripheral  blood  cells  of  chil-
ren,  collected  with  EDTA  as  the  anticoagulant  up  to  three
onths  after  birth,  using  the  kit  EasyPrep  DNA  Mini  I (Easy-
en,  Favorgen  Biotech  --  Austria).  The  DNA  ampliﬁcation
f  T.  gondii  was  performed  using  the  method  described
y  Homan  et  al.19 Primers  Tox4  (CGCTGCAGGGAGGAAGAC-
AAAGTTG)  and  Tox5  (CGCTGCAGACACAGTGCATCTGGATT)
ere  used  for  the  ampliﬁcation  of  a  fragment  of  529  base
airs  (bp;  GenBank  No.  AFI46527)  of  T.  gondii  DNA.  PCR  was
erformed  in  a  ﬁnal  volume  of  22.5  L,  containing  2.5  L of
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Figure  1  Pattern  recognition  of  RH  strain  proteins  of  Toxoplasma  gondii  by  IgG  antibodies  using  the  Western  blotting  (IgG-
WB) method  performed  with  serum  samples  from  mothers  with  acquired  toxoplasmosis  during  pregnancy  and  their  children  with
suspected congenital  toxoplasmosis.  (A)  Positive  IgG-Western  blotting  for  congenital  toxoplasmosis.  Equal  bands  recognized  by  IgG
antibodies, with  stronger  intensity  in  the  child  sample  compared  to  maternal  sample.  (B)  Positive  IgG-Western  blotting  for  congenital
toxoplasmosis.  Different  bands  recognized  by  IgG  from  the  child  sample  as  compared  to  the  maternal  sample.  (C)  Negative  IgG-
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pWestern blotting  for  congenital  toxoplasmosis.  Equal  bands  reco
C, child;  PC,  positive  control;  NC,  negative  control.
DNA  extracted  from  the  sample;  1.0  L of  1.0  mM  for  each
primer,  100  mM  of  dNTP  (Invitrogen,  Life  Technologies  --  CA,
United  States),  60  mM  Tris--HCl  (pH  9.0),  15  mM  (NH4)2SO4,
2  mM  MgCl2,  and  0.25  L  Taq  DNA  polymerase  (Invitrogen,
Life  Technologies  --  CA,  United  States),  also  completed  with
7.75  L  of  Milli  Q  water.  The  ampliﬁcation  was  performed
with  35  cycles  in  a  thermal  cycler  (PTC-100,  MJ  Research
--  CA,  United  States),  using  the  following  cycling  condition:
7  min  at  94 ◦C  for  denaturation  in  the  1st  cycle,  followed  by
33  cycles  of  1  min  at  94  C  for  denaturation,  1  min  at  55 ◦C  for
annealing,  and  1  min  at  72 ◦C  for  extension;  cycle  35  was  fol-
lowed  by  a  ﬁnal  extension  of  10  min  at  72 ◦C.  Aliquots  of  each
PCR  product  were  subjected  to  electrophoresis  in  2%  agarose
gel.  RH  strain  Tachyzoites  (107/mL)  had  their  DNA  extracted
to  be  used  as  positive  control.  The  water  was  regarded  as
the  negative  control.  Positive  and  negative  control  samples
for  T.  gondii  were  included  in  each  test.
Statistical  analysis
The  statistical  analysis  was  done  on  GraphPad  Prism  5
(GraphPad  Software,  Inc.  --  San  Diego,  United  States).  Cat-
egorical  variables  were  expressed  as  absolute  number  (n)
and  percentage  (%)  and  analyzed  by  the  chi-squared  test
or  Fisher’s  exact  test.  Parameters  of  sensitivity,  speciﬁcity,
positive  predictive  value  (PPV),  and  negative  predictive
value  (NPV)  were  calculated,  with  a  conﬁdence  interval  (CI)
of  95.0%.  Values  of  p  <  0.05  were  considered  statistically  sig-
niﬁcant.
f
b
ad  by  IgG  antibodies  from  child  and  mother  samples.  M,  mother;
The  study  was  approved  by  the  Ethics  Committee  for
esearch  Involving  Human  Beings.  All  mothers  participated
oluntarily  and  signed  the  informed  consent.
esults
f  the  15  children  with  CT,  12  (80.0%)  were  symptomatic
nd  met  the  clinical  criteria  for  the  deﬁnition  of  the  disease
nine  with  cerebral  calciﬁcation,  eight  with  chorioretinitis,
nd  four  with  hydrocephalus),  six  (40.0%)  presented  reactiv-
ty  for  anti-T. gondii  IgM,  ﬁve  (33.3%)  showed  elevation  of
nti-T.  gondii  IgG  in  the  ﬁrst  months  of  life,  and  one  (6.7%)
howed  persistence  of  anti-T. gondii  IgG  titers  in  sequential
amples.  Five  of  the  seven  children  (71.4%)  who  under-
ent  PCR  to  detect  T.  gondii  DNA  showed  positive  results
Table  1).
Among  the  15  children  with  CT,  the  IgG-WB  test  was  pos-
tive  in  nine  (60.0%),  and  among  the  32  children  without  CT,
he  test  was  positive  in  18  (56.3%),  which  resulted  in  a  sen-
itivity  of  60.0%  (95%  CI:  32.3--83.7%),  speciﬁcity  of  43.7%
95%  CI:  26.4--62.3%),  PPV  of  33.3%  (95%  CI:  16.5--54.0%),
nd  NPV  of  70.0%  (95%  CI:  45.7--88.1%)  (p  =  0.05875).  Among
he  children  with  CT,  two  presented  negative  IgG-WB  and
ere  positive  for  anti-T. gondii  IgM;  ﬁve  children  presented
ositive  IgG-WB  and  were  negative  for  anti-T. gondii  IgM,
our  presented  both  tests  as  positive,  and  four  presented
oth  tests  as  negative.
The  molecular  weight  (MW)  of  the  protein  recognized  by
nti-T.  gondii  IgG  in  the  serum  of  children  with  CT  ranged
620  Capobiango  JD  et  al.
Table  1  Clinical  and  laboratory  characteristics  of  15  children  with  congenital  toxoplasmosis,  from  June  2011  to  June  2014.
Case  Anti-T.
Gondii  IgM
PCR IgG  1st  samplea Following
IgGb
Western
blottingb
Signs  and  symptoms  in
the  1st  month  of  life
IFI  CL
1  Negative  NR  1:512,000  NR  ↓  Negative  Chorioretinitis  +  calciﬁcation  +
hydrocephalus
2 Positive  NR  1:32,000  926.8  ↑  Positive  Chorioretinitis  +  calciﬁcation
3 Positive  NR  1:512,000  NR  ↓  Positive  Vitritis  (chorioretinitis
after)  +  calciﬁcation  +  hydrocephalus
4 Negative  NR  <1:16  NR  ↑  Positive  Chorioretinitis
5 Negative  NR  1:1024  162.0  ↔  Positive  Calciﬁcation
6 Negative  Positive NR  200.0  ↑  Positive Asymptomatic
7 Negative  Positive 1:32,000  147.5  NR  Negative  Hydrocephalus
8 Negative  Negative  1:8000  312.0  ↑  Negative  Asymptomatic
9 Negative  Positive  1:512,000  175.6  ↓  Negative  Asymptomatic
10 Positive  Positive  1:512,000  188.1  ↓  Positive  Chorioretinitis
11 Negative  Positive  1:32,000  139.8  NR  Positive  Calciﬁcation
12 Positive  Negative  NR  84.8  ↑  Negative  Vitritis  +  calciﬁcation
13 Positive  NR  NR  200.0  NR  Positive  Chorioretinitis  +  calciﬁcation
14 Negative  NR  NR  173.9  ↓  Positive  Chorioretinitis  +  calciﬁcation  +
hydrocephalus
15 Positive  NR  NR  1655.0  ↓  Negative  Chorioretinitis  +  calciﬁcation
PCR, polymerase chain reaction for DNA detection of Toxoplasma gondii;  IFI, indirect immunoﬂuorescence for detection of IgG anti-T.
gondii; CL, microparticle chemiluminescence immunoassay for the detection of anti-T. gondi IgG, expressed in UI/mL; NR, unrealized;
↑, increased antibody levels of anti-T. gondii IgG in serial serum samples; ↔,  persistence of levels of anti-T. gondii IgG in serum samples
during follow-up; ↓, decline of antibodies.
a Sample collected in the 1st month of life.
dren in treatment.
f
I
r
t
o
o
s
a
i
t
a
1
(
p
C
ﬁ
C
p
P
ﬁ
C
p
w
g
s
e
P 94
0
10
20
30
40
P 78 P 58
With congenital toxoplasmosis Without congenital toxoplasmosis
 P 44
Antigenic bands (kDa)
Fr
e
qu
en
cy
,
 
%
 P 31 P 30 P 13
Figure  2  Distribution  of  the  most  frequent  Toxoplasma  gondii
proteins  recognized  by  IgG  antibodies  in  the  serum  of  children
with congenital  toxoplasmosis  and  children  without  the  disease,
according  to  their  molecular  weight  (kDa)  (p  >  0.05  for  all  the
recognized  proteins).b Sample collected within the ﬁrst 3 months of life, with all chil
rom  2  to  94  kDa,  and  regarding  the  proteins  recognized  by
gG  antibodies  in  the  serum  of  the  non-infected,  the  MW
anged  from  1  to  160  kDa.  Among  the  nine  children  diagnosed
hrough  IgG-WB,  seven  presented  different  bands  from  those
bserved  in  the  maternal  serum  and  two  presented  bands
f  greater  intensity  than  those  presented  by  their  mother’s
ample.  The  dominant  bands  that  were  recognized  by  IgG
ntibodies  from  samples  of  children  with  CT  and  the  non-
nfected  are  demonstrated  in  Fig.  2.
As  for  the  26  samples  from  patients  with  other  diseases,
wo  showed  no  reactivity  and  24  showed  reactivity  for  IgG
ntibodies  that  recognized  proteins  with  MW  ranging  from
7  to  118  kDa.  Those  most  frequently  recognized  were  p22
11/40.7%),  p34  (9/33.3%),  p38  (8/29.6%),  p94  (6/22.2%),
56  (5/18.5%),  and  p30  (5/18.5%).
The  analysis  of  the  results  of  anti-T. gondii  IgM  using
L  showed  sensitivity  of  40.0%  (95%  CI:  16.3--67.6%),  speci-
city  of  100.0%  (95%  CI:  89.1--100.0%),  PPV  of  100.0%  (95%
I:  54.1--100.0%),  and  NPV  of  78.1%  (95%  CI:  62.4--89.4%;
 =  0.0005).  For  the  detection  of  the  parasite’s  DNA  using
CR,  the  sensitivity  was  71.4%  (95%  CI:  29.0--96.3%),  speci-
city  of  100.0%  (95%  CI:  69.2--100.0%),  PPV  of  100.0%  (95%
I:  47.8--100.0%),  and  NPV  of  83.3%  (95%  CI:  51.6--98.0%;
 =  0.0034).
The  sensitivity  and  speciﬁcity  of  IgG-WB  when  associated
ith  other  markers  of  CT  --  such  as  the  presence  of  anti-T.
ondii  IgM,  positive  PCR,  and  the  clinical  symptoms  --  are
hown  in  Table  2.
IgG-WB  was  positive  in  six  of  nine  patients  (66.7%)  with
ye  injuries  and  in  three  of  six  patients  (50.0%)  with  CT  with-
o
C
P
1ut  eye  injuries  (p  =  0.6224),  with  sensitivity  of  66.7%  (95%
I:  29.9--92.5%),  speciﬁcity  of  50.0%  (95%  CI:  11.8--88.2%),
PV  of  66.7%  (95%  CI:  29.9--92.5%),  and  NPV  of  50%  (95%  CI:
1.8--88.2%).
Western  blotting  for  congenital  toxoplasmosis  
Table  2  Sensitivity  and  speciﬁcity  of  the  Western  blot-
ting method  for  the  detection  of  anti-Toxoplasma  gondii  IgG
(IgG-WB),  anti-Toxoplasma  gondii  IgM  test,  the  polymerase
chain  reaction  (PCR)  to  Toxoplasma  gondii,  and  the  presence
of clinical  symptoms  compatible  with  congenital  toxoplas-
mosis,  assessed  in  series  and  in  parallel,  according  to  the
presence  or  absence  of  congenital  toxoplasmosis.
Test  Sensitivity
(%)
Speciﬁcity
(%)
IgG-WB+  60.0  43.7
IgM T.  gondii+  40.0  100.0
IgM anti-T.  gondii  or  IgG-WB+ 76.0  43.7
IgM anti-T.  gondii  and  IgG-WB+ 24.0 100.0
PCR+  71.7  100.0
PCR +  or  IgG-WB+  89.1  43.7
PCR +  and  IgG-WB+  42.6  100.0
Symptoms+  80.0  100.0
Symptoms  +  or  IgG-WB+ 92.0  43.7
Symptoms  +  and  IgG-WB+ 48.0  100.0
IgG-WB, Western blotting for diagnosis of congenital infec-
tion with detection of IgG antibodies; anti-Toxoplasma gondii
IgM detected by chemiluminescence; Symptoms, presence of
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when  assayed  by  CL  and  IIF  methods  after  treatment.  How-symptoms and/or clinical signs consistent with congenital toxo-
plasmosis; +, positive test.
Discussion
The  diagnosis  of  CT  is  a  challenge  in  clinical  practice,
because  the  sensitivity  of  anti-T. gondii  IgM  using  conven-
tional  serological  methods  varies  widely,  from  48.3%  to
75.0%.3--5 The  absence  of  anti-T. gondii  IgM  can  be  justiﬁed
by  the  fact  that  fetal  infection  occurred  at  the  beginning  of
pregnancy  or  as  a  result  of  maternal  treatment  for  toxo-
plasmosis  carried  out  during  the  ﬁrst  two  trimesters  of
pregnancy,  which  would  cause  blockage  or  delay  of  the
immune  response.20 Moreover,  the  delay  or  the  absence  of
detectable  immune  response  by  standard  methods  (IgG  and
IgM  dosage  or  WB)  could  be  related  to  differences  in  the
individual  immune  response.  Another  disadvantage  of  this
marker  is  the  delay  in  the  sample  collection,  with  decreased
positivity  of  IgM  after  the  ﬁrst  30  days  of  life.21 Therefore,  it
is  often  necessary  to  monitor  the  serological  results  with  the
identiﬁcation  of  stable  or  increasing  titers  of  anti-T. gondii
IgG,  which  delays  the  diagnosis  and  causes  uncertainty  to  the
family.16 In  this  context,  the  IgG-WB  can  be  used  to  compare
the  patterns  of  antibodies  against  T.  gondii  in  serum  samples
from  the  mothers  and  their  children,  and  determine  if  the
antibodies  are  transmitted  passively  or  synthesized  by  the
fetus  or  infant  in  cases  of  CT.15
Other  authors  have  observed  a  higher  contribution  of  IgG-
WB  to  the  diagnosis  of  CT  in  the  ﬁrst  months  of  life.22,23
In  addition,  the  association  of  IgG-WB  with  other  sero-
logical  methods  can  increase  the  probability  of  diagnosis.
In  a  cohort  of  children,  the  sensitivity  of  IgG-WB  was
82.4%  and  increased  to  85.7%  when  IgG-WB  was  associ-
ated  with  the  presence  of  IgM  and/or  IgA  anti-T. gondii
using  ELISA.16 Another  study  showed  that  the  combination
of  IgA  and  IgM  immunocapture  tests,  the  analysis  of  IgG  an
IgM  WB  patterns,  and  the  combination  of  both  techniques
e
a
p621
llowed  the  detection  of  94.0%,  94.0%,  and  100.0%  of  cases,
espectively.24
The  IgG-WB  results  obtained  in  the  present  study  are
lose  to  those  found  by  other  authors,  who  reported  sen-
itivity  of  73.5%.18 These  same  authors  reported  that  the
ombination  of  IgG-WB  and  IgM-WB  increased  the  sensitivity
o  86.5%.18
The  lower  sensitivity  obtained  in  this  study  can  be
xplained,  in  part,  because  all  the  patients  with  suspected
T  were  treated  with  sulfadiazine,  pyrimethamine,  and
olinic  acid  during  the  investigation,  which  could  inhibit  the
eosynthesis  of  antibodies.20
Another  strategy  to  improve  the  sensitivity  of  this  pro-
osed  method  is  the  repetition  of  IgG-WB  throughout  the
rst  three  months  of  life.8 In  a  study  with  samples  collected
t  birth,  the  sensitivity  of  anti-T. gondii  IgM  by  conventional
ethods  (ISAGA  and  ELISA)  was  52.0%  and  for  WB  (with  IgG
nd  IgM)  was  67.0%.  By  combining  the  two  methods,  the
ensitivity  increased  to  78.0%  at  birth  and  to  85.0%  at  three
onths  of  life,  with  the  detection  of  94.0%  of  the  cases  of
T.17
The  present  study  analyzed  some  sequential  samples  of
gG-WB.  Among  infected  children,  with  false-negative  result
n  the  ﬁrst  sample  by  IgG-WB,  two  of  six  (33.3%)  chil-
ren  have  different  recognized  proteins  in  relation  to  the
aternal  sample  in  the  second  collection,  characterizing
eosynthesis  of  anti-T. gondii  IgG,  which  justiﬁes  the  need
or  repetition  of  IgG-WB  in  serial  samples.
In  a  previous  analysis,  the  time  of  maternal  sample  col-
ection  inﬂuenced  the  outcome  of  the  IgG-WB  test,  because
others  who  received  treatment  for  toxoplasmosis  during
regnancy  may  no  longer  react  to  the  antigens  of  T.  gondii
n  the  late  after  birth  period,  with  false-negative  result.16
n  the  present  study,  this  phenomenon  was  observed  in  one
other  of  an  infected  child.  However,  the  majority  of  moth-
rs  showed  an  increase  in  the  number  of  bands  recognized
n  the  samples  collected  immediately  after  the  interruption
f  treatment  at  delivery.
In a  previous  study,  the  MW  of  antigenic  bands  that  were
ecognized  by  IgG  of  neonates  with  CT  varied  from  21  to
16  kDa.18 In  the  present  study,  similar  to  that  found  by
ther  authors,15,16 the  antibodies  found  with  high  frequency
n  infected  children  were  those  against  the  proteins  with  MW
igher  than  30  kDa.  The  differences  in  the  MW  of  recognized
roteins  reported  by  previous  studies  can  be  explained  by
ifferent  methodological  requirements,  such  as  the  prepara-
ion  of  the  T.  gondii  antigen,  conditions  of  electrophoresis  on
crylamide  gel,  and  the  serum  dilutions.20 Another  explana-
ion  is  the  genetic  diversity  among  strains  of  T.  gondii, which
an  lead  to  the  recognition  of  different  proteins,  besides
he  fact  that  some  individuals  present  IgG  that  recognizes
ultiple  proteins,  while  others,  a  single  protein.25
In  the  present  study,  IgG-WB  was  also  useful  in  demon-
trating  the  active  synthesis  of  anti-T. gondii  IgG  in  patients
ith  IgG  non-reactive  by  conventional  methods.  In  Patient
,  with  anti-T. gondii  IgG  titer  <  1:16  by  IIF  in  the  ﬁrst  sam-
le  and  a slight  increase  in  sequential  samples  (maximum
f  1:64),  disappearance  of  IgG  antibodies  was  observedver,  by  the  IgG-WB  method,  it  was  possible  to  demonstrate
nti-T.  gondii  IgG,  which  recognized  the  proteins  p22  and
46,  which  were  absent  in  the  maternal  serum.  After  12
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onths  of  life,  this  child,  who  showed  chorioretinitis  scar-
ing,  remained  non-reactive  to  anti-T. gondii  IgG  antibodies
valuated  by  CL  and  IIF;  however,  positivity  was  shown  for
gG-WB.
CT  with  non-reactivity  for  anti-T. gondii  IgG  and  IgM  may
esult  from  toxoplasmosis  treatment  on  the  mother  and
eonate.20 The  treatment  of  the  child  for  a  year  after  birth
ay  also  cause  antibody  non-reactivity.  However,  in  most  of
hese  cases  there  is  detection  of  anti-T. gondii  IgG  soon  after
reatment  interruption,  called  the  rebound  effect.1,7,20
In  this  present  study,  Patient  1  showed  non-reactivity,  but
resented  detectable  anti-T. gondii  antibodies  after  inter-
uption  of  the  treatment.  Similarly  to  Patient  4,  Patients  6,
,  and  9  also  showed  a  drop  in  antibodies  up  to  the  point
f  non-reactivity  and  remained  thus  after  interruption  of
reatment.  It  is  possible  that  these  patients  no  longer  rec-
gnize  the  proteins  p30  and  p35  present  in  the  CL  test,  which
ustiﬁes  the  non-reactivity  in  this  test  with  the  evolution  of
he  infection.
Therefore,  instead  of  evaluating  only  the  persistence  of
nti-T.  gondii  IgG  by  CL,  the  authors  suggest  the  use  of
gG-WB  in  serological  monitoring,  since  the  infected  child
an  produce  antibodies  against  other  proteins  of  the  para-
ite  and  thus  remains  positive  after  12  months  age.  In  this
ase,  the  absence  of  anti-T. gondii  IgG  in  the  CL  may  not
xclude  CT,  which  would  also  justify  the  lower  speciﬁcity  of
gG-WB  found  during  the  present  study  compared  to  previ-
us  studies.16--18,22,23 However,  more  studies  should  be  done
efore  using  IgG-WB  in  serological  monitoring.
According  to  a  study  carried  out  in  a  Brazilian  popula-
ion,  patients  with  IgM  reactive  by  WB  method  (IgM-WB)
howed  greater  risk  for  active  macular  injury  than  patients
ith  negative  IgM-WB.18 However,  no  signiﬁcant  difference
as  found  between  positivity  of  IgG-WB  and  the  presence
f  macular  injury,  as  in  the  present  study.  It  is  not  clear
hether  there  are  speciﬁc  proteins  of  T.  gondii  strains  asso-
iated  with  eye  injuries  and  if  they  could  explain  the  greater
requency  of  eye  injury  on  Brazilian  children  with  CT  than
n  other  countries.26 The  main  limitation  to  this  present
tudy  was  the  absence  of  evaluation  of  the  samples  with
gM-WB,  which  could  improve  the  diagnostic  sensitivity  of
he  test.
The  technical  procedure  for  IgG-WB  is  of  low  complexity
nd  with  available  cost,  which  makes  it  viable  in  the  lab-
ratory  routine.  The  drawback  of  the  in-house  method  is
ts  slowness,  which  could  be  reduced  with  standardization
f  a  set  of  reagents  to  be  produced  in  Brazil.  The  semi-
utomation  of  the  method  with  the  use  of  a  program  for  the
eading  of  band  intensity  viewed  though  WB  would  facilitate
he  reading  and  the  reproducibility  of  results.20
The  results  reinforce  the  usefulness  of  the  IgG-WB
ethod  for  serological  evaluation  of  patients  with  CT,  with
reater  sensitivity  than  the  detection  of  anti-T. gondii  IgM  by
onventional  methods.  Therefore,  IgG-WB  can  be  used  for
he  early  diagnosis  of  CT  in  combination  with  other  markers
f  the  congenital  T.  gondii  infection.unding
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